VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,568,126 | -98.7% | 58,273 | -98.6% | 0.01% | -99.2% |
| Q4 2022 | $120,112,168 | +13.5% | 4,190,934 | -4.5% | 0.64% | +2.1% |
| Q3 2022 | $105,819,000 | -17.9% | 4,387,189 | -6.8% | 0.63% | -33.7% |
| Q2 2022 | $128,836,000 | -21.9% | 4,705,477 | +9.4% | 0.95% | -32.0% |
| Q1 2022 | $164,905,000 | +598.8% | 4,300,000 | +437.0% | 1.40% | +372.0% |
| Q3 2021 | $23,598,000 | -70.5% | 800,746 | -66.0% | 0.30% | -67.6% |
| Q2 2021 | $80,084,000 | -58.6% | 2,356,805 | -60.4% | 0.91% | -70.2% |
| Q1 2021 | $193,375,000 | -40.7% | 5,950,000 | -34.3% | 3.07% | -33.8% |
| Q4 2020 | $325,981,000 | +131.2% | 9,050,000 | +151.4% | 4.64% | +130.4% |
| Q3 2020 | $140,976,000 | +296.2% | 3,600,000 | +271.1% | 2.01% | +285.4% |
| Q2 2020 | $35,583,000 | -34.3% | 970,100 | -58.7% | 0.52% | -76.5% |
| Q1 2020 | $54,184,000 | – | 2,351,734 | – | 2.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |